Otros idiomas Guangdong Hybribio Biotech Co.,Ltd.

Acciones

300639

CNE100002N51

Precio de cierre Shenzhen S.E. Otros sitios de cotización 06/09/2024			Varia. Cinco días.	Varia. 1 de enero.
5,240 ^CNY	-2,24 %		-8,39 %	-43,90 %

28/08	Guangdong Hybribio Biotech Co.,Ltd. Resultados del semestre finalizado el 30 de junio de 2024	CI
16/07	Guangdong Hybribio Biotech obtiene la licencia para instrumentos de laboratorio clínico	MT

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	28/08
Guangdong Hybribio Biotech Obtains License for Clinical Laboratory Instruments	16/07
Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on June 28, 2024.	02/07
Guangdong Hybribio Biotech Co.,Ltd. announces an Equity Buyback for CNY 60 million worth of its shares.	27/06
Guangdong Hybribio Biotech Co.,Ltd. authorizes a Buyback Plan.	27/06
Hybribio Biotech Gets Patent for Spinal Muscular Atrophy Gene Kit	21/05
Hybribio Biotech Unit Gets Nod to Market Deafness Gene Detection Kit in China	16/05
Guangdong Hybribio Biotech Co.,Ltd. Approves Cash Dividend for the Year 2023	15/05
Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.	07/05
Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback announced on February 6, 2024, has closed with 4,445,000 shares, representing 1.51% for CNY 30.1 million.	07/05
Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04
Guangdong Hybribio Biotech Co.,Ltd. Proposes Final Dividend for the Year 2023	24/04
Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	23/04
Tranche Update on Guangdong Hybribio Biotech Co.,Ltd.'s Equity Buyback Plan announced on February 6, 2024.	02/04
Guangdong Hybribio Biotech, Subsidiary Get Patent from Brazil for Isolation Method	22/03
Hybribio Calls for Raising International HPV Awareness	04/03
Hybribio Biotech's Unit Secures Registration Certificate for Nucleic Acid Analysis System	23/02
Guangdong Hybribio Biotech Co.,Ltd. announces an Equity Buyback for CNY 60 million worth of its shares.	05/02
Guangdong Hybribio Biotech Co.,Ltd. authorizes a Buyback Plan.	05/02
Guangdong Hybribio Biotech Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/10/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Guangdong Hybribio Biotech Co.,Ltd.

Acciones

300639

CNE100002N51

Otros idiomas

Filtros